Innovating Works

CANARIAS FORESTAL

Activa
ImmunoBioSynth: Synergistic engineering of anti tumor immunity by synthetic biomaterials CANARIAS FORESTAL participó en un H2020: ERC-2018-COG Immunotherapy holds the potential to dramatically improve the curative prognosis of cancer patients. However, despite significant progress,...
2019-02-27 - 2024-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.